Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label, single center study to assess the pharmacokinetics, safety and tolerability of multiple administrations of 30 mg PMI-150 (intranasal ketamine) in healthy adult volunteers

Trial Profile

An open label, single center study to assess the pharmacokinetics, safety and tolerability of multiple administrations of 30 mg PMI-150 (intranasal ketamine) in healthy adult volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Aug 2008

At a glance

  • Drugs Ketamine (Primary)
  • Indications Acute pain; Cancer pain
  • Focus Pharmacokinetics
  • Sponsors Javelin Pharmaceuticals
  • Most Recent Events

    • 13 Aug 2008 Pharmacokinetic data presented at the Department of Defense's 2008 Advanced Technology Applications for Combat Casualty Care (ATACCC) Conference.
    • 31 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top